Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer

Table 2 Relationship between serum HULC and pathological parameters of pancreatic cancer (mean ± SD)

Clinicopathological parameters	n	HULC	t	P value
Gender			0.016	0.987
Male	43	4.994 ± 1.520
Female	17	4.987 ± 1.451
Age (yr)			0.969	0.336
< 60	35	4.834 ± 1.498
≥ 60	25	5.212 ± 1.477
Tumor size (cm)			3.923	< 0.001b
< 2	29	4.293 ± 1.368
≥ 2	31	5.900 ± 0.988
T staging			5.248	< 0.001b
T1/T2	38	4.354 ± 1.196
T3	22	6.093 ± 1.304
N staging			1.126	0.265
N0	39	4.743 ± 1.497
N1	21	5.286 ± 1.281
M staging			5.120	< 0.001b
M0	32	4.221 ± 1.202
M1	28	5.872 ± 1.295
Differentiation			0.829	0.411
High/medium	49	4.916 ± 1.420
Low	11	5.329 ± 1.802
Nerve involvement			0.401	0.690
No	55	4.971 ± 1.386
Yes	5	5.283 ± 2.876
Vascular invasion			3.660	< 0.001b
No	40	4.540 ± 1.324
Yes	20	5.896 ± 1.412
Smoking history			0.101	0.920
No	36	4.976 ± 1.405
Yes	24	5.016 ± 1.637
History of alcoholism			0.494	0.623
No	42	4.929 ± 1.64
Yes	18	5.138 ± 1.084

^bP < 0.01 for between-group comparisons.